ME Therapeutics' Salim Dhanji on making the patient's body the bioreactor
The Vancouver immunologist on myeloid cells as a delivery route, STING for cold tumours, and why in vivo CAR could land near the price of a checkpoint inhibitor.
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
✨ Onyx Summary Guardant Health has announced a partnership with PathGroup to expand access to its FDA-approved Shield™ blood test for colorectal cancer (CRC) screening. The collaboration will bring Shield to more than 250 hospitals and health systems, 15,000+ affiliated physicians, and millions of patients across 25 states through